The login/sign up screen for a Twitter account is seen on a laptop computer Tuesday, April 27, 2021, in Orlando, Fla. Twitter is rolling out a subscription service, starting in Canada and Australia, that offers perks like an undo button for subscribers. (AP Photo/John Raoux)
Twitter is rolling out a subscription service, starting in Canada and Australia, that offers perks like an undo button for subscribers.
The “Twitter Blue” subscription service will offer features that users have long asked for — but still no edit button. It includes bookmark folders for organizing saved content; an “Undo tweet" feature that gives users 30 seconds to cancel a sent tweet before it appears; a “reader mode" that makes threaded tweets easier to read; and customizable app icons and color themes.
Subscribers will also get dedicated customer support, meaning issues they report could get attention faster than other users.
The subscription costs 3.50 Canadian dollars ($2.89) a month and 4.50 Australian dollars ($3.45). There's no timeline for rolling out the service in other countries.
Twitter has been adding new features to attract new users. The social media site has nearly 200 million daily users, fewer than other social media networks. Facebook had 1.88 billion daily users on average in March 2021. Snapchat, meanwhile, had 280 million average daily active users in the first quarter.
Twitter shares closed Thursday down 15 cents at $57.01.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
